| Identification | Back Directory | [Name]
Ethanesulfonamide, N-[(2S,3S)-2-[(2,3'-difluoro[1,1'-biphenyl]-3-yl)methyl]-1-(2-hydroxy-2-methyl-1-oxopropyl)-3-pyrrolidinyl]- | [CAS]
2274802-89-8 | [Synonyms]
Suntinorexton
Ethanesulfonamide, N-[(2S,3S)-2-[(2,3'-difluoro[1,1'-biphenyl]-3-yl)methyl]-1-(2-hydroxy-2-methyl-1-oxopropyl)-3-pyrrolidinyl]- | [Molecular Formula]
C23 H28 F2 N2 O4 S | [MOL File]
2274802-89-8.mol | [Molecular Weight]
466.54 |
| Hazard Information | Back Directory | [Uses]
Suntinorexton, a heterocyclic compound, is an orexin type 2 receptor agonist extracted from patent WO2019027058A1, page 288[1]. | [IC 50]
OX2 Receptor | [References]
[1] Kajita Y, et, al. Heterocyclic compound and use thereof. WO2019027058A1. |
|
|